With a career spanning over 25 years, George Vlachos is renowned for his expertise and leadership in the pharmaceutical industry.
As Co-Founder and Co-CEO of Akesa, George’s focus on global sourcing and procurement of comparator pharmaceutical products has been crucial in navigating the complex challenges of clinical trial management. His proactive approach and vast network enhance Akesa’s capabilities in securing essential pharmaceuticals, ensuring the highest standards of quality in clinical operations.
George has a deep knowledge of the clinical trial supply chain and its associated complexities developed across his vast career working at industry giants including contract research organisation (CRO) PPD and IQVIA, and with global pharmaceutical company at Lilly. During his early career, George excelled in managing large scale clinical trials across APAC as Region PM and developing a clinical trial distribution depot and GMP facility in Australia. George’s leadership within the industry and vast network helps to position Akesa as a leader in pharmaceutical sourcing for clinical trials, supporting substantial advances in global health.
- Demystifying the clinical trial supply chain
Explore the complexities of the clinical trial supply chain. From sourcing and manufacturing to storage and distribution of trial supplies, learn how each link in the chain has a critical role in ensuring medicines reach clinical trial sites and patients efficiently and securely. - APAC shaping future healthcare outcomes
With a population that spans over half the globe, Asia-Pacific presents a dynamic setting for clinical research that could help shape future healthcare outcomes worldwide. Explore the strategic advantages and inherent challenges faced when conducting clinical trials in the APAC region. - Federal Budget 2024-25: Key outcomes for Australian clinical trial sector
The Australian Federal Budget for FY24-25 has outlined significant funding and initiatives to support the health sector, with a strong focus on clinical trials and medical research. Explore the key outcomes that will impact the clinical trial sector in Australia.
